Gestational Diabetes

IWBCA
Feb 17
10 min read

Gestational diabetes is glucose intolerance first recognized during pregnancy that increases health risks for both the pregnant person and baby, but can often be managed successfully with early detection, careful monitoring, and coordinated medical care.

Overview

What is gestational diabetes?

Gestational diabetes mellitus is a form of diabetes in which elevated blood glucose is first identified during pregnancy. It reflects an imbalance between rising insulin resistance in pregnancy and the pancreas’s ability to produce enough insulin to maintain normal glucose levels. It typically develops in the second or third trimester and usually resolves after delivery, but it signals a higher lifetime risk of future type 2 diabetes and cardiovascular disease for the mother and metabolic problems for the child.

Gestational diabetes is one of the most common medical complications of pregnancy worldwide. Estimates suggest that dysglycemia in pregnancy, including gestational diabetes, affects about one in six pregnancies globally, with gestational diabetes accounting for a substantial proportion of those cases.

Epidemiology and Impact

How common is gestational diabetes?

The prevalence of gestational diabetes varies across populations, screening approaches, and diagnostic criteria, but it is consistently recognized as one of the most frequent medical complications of pregnancy. Large analyses suggest that approximately 5 to 15 percent of pregnancies are affected, with some cohorts reporting rates close to one in seven pregnant individuals. This burden has increased in parallel with rising rates of obesity, insulin resistance, and type 2 diabetes in people of childbearing age.

Global and Regional Prevalence: Studies from multiple regions report gestational diabetes in roughly 5 percent of pregnancies in some European and African cohorts and in over 10 percent of pregnancies in several Asian and North American cohorts. When health systems apply universal screening or more inclusive diagnostic thresholds, observed prevalence is higher, highlighting how both underlying metabolic risk and local screening practices shape the number of pregnancies identified with gestational diabetes.
Impact on Pregnancy Outcomes: Gestational diabetes is clinically important because it increases the risk of complications for both the pregnant person and the baby. It is associated with higher rates of hypertensive disorders of pregnancy, polyhydramnios, induction of labor, cesarean delivery, shoulder dystocia, birth trauma, neonatal hypoglycemia, jaundice, and admission of newborns to intensive care units. Even when maternal blood glucose is only moderately elevated, the risks of large-for-gestational-age birthweight, excessive fetal growth, operative delivery, and early metabolic disturbances in the newborn rise compared with pregnancies in which glucose levels remain within normal ranges.
Long-Term Health Impact: The consequences of gestational diabetes extend beyond delivery. After a pregnancy complicated by gestational diabetes, the parent has a substantially higher lifetime risk of developing type 2 diabetes, with many studies estimating an approximate eightfold increase compared with individuals who had normoglycemic pregnancies. In some cohorts, a significant proportion of those with prior gestational diabetes progress to type 2 diabetes within the first decade postpartum if no preventive measures are implemented. Children exposed to gestational diabetes in utero face increased risks of childhood obesity, impaired glucose regulation, and cardiometabolic disease later in life, underscoring gestational diabetes as a critical window for prevention for both generations.

Pathophysiology

What is happening in the body with gestational diabetes?

Pregnancy is characterized by progressive insulin resistance driven by placental hormones and physiological changes that ensure sufficient glucose supply for the growing fetus. In most pregnancies, the pancreatic beta cells compensate by producing more insulin. In gestational diabetes, this compensation is incomplete, leading to hyperglycemia.

Physiological Insulin Resistance in Pregnancy: Hormones such as human placental lactogen, progesterone, cortisol, and placental growth hormone reduce insulin sensitivity, particularly in the second and third trimesters. As a result, fasting and post-meal glucose levels tend to rise unless insulin secretion increases appropriately.
Beta-Cell Dysfunction and Genetic Susceptibility: People who develop gestational diabetes often have pre-existing beta-cell vulnerability or subtle abnormalities in insulin secretion that become apparent when pregnancy-related insulin resistance intensifies. Family history of diabetes, prior gestational diabetes, and certain genetic variants increase susceptibility.
Placental and Fetal Effects: Persistent maternal hyperglycemia increases glucose transfer across the placenta. The fetus responds with increased insulin production, which acts as a growth factor and contributes to accelerated growth, increased fat mass, and an increased risk of cardiometabolic disease later in life.

Risk Factors

Who is at increased risk for gestational diabetes?

Gestational diabetes can occur in any pregnancy, but certain characteristics substantially raise the risk. Identifying these factors helps clinicians decide who may benefit from early testing and closer monitoring.

Maternal Age: The likelihood of gestational diabetes rises steadily with advancing maternal age. Large meta-analyses demonstrate a clear increase in risk across age groups beyond the mid-twenties, with particularly high rates reported in individuals aged 35 years and older.
Pre-Pregnancy Weight and Metabolic Health: Overweight and obesity prior to conception are among the strongest modifiable risk factors for metabolic health. Central adiposity, physical inactivity, and prior evidence of insulin resistance or metabolic syndrome further increase risk.
History of Gestational Diabetes or Adverse Pregnancy Outcomes: A prior pregnancy affected by gestational diabetes, unexplained stillbirth, or the birth of a large-for-gestational-age infant significantly increases the likelihood of recurrence in subsequent pregnancies.
Family and Personal History of Glucose Abnormalities: A family history of type 2 diabetes in first-degree relatives, pre-pregnancy impaired fasting glucose, impaired glucose tolerance, or polycystic ovary syndrome is associated with a higher risk of gestational diabetes.
Ethnic and Social Determinants: Certain ethnic groups, including many Asian, Hispanic/Latina, Indigenous, Pacific Islander, and African-descent populations, experience higher rates of gestational diabetes. Social factors, such as limited access to healthy food, safe environments for physical activity, and prenatal care, also contribute to an elevated risk.

Symptoms

What symptoms can occur with gestational diabetes?

Gestational diabetes often causes few or no noticeable symptoms, which is why routine screening is essential. When symptoms occur, they may resemble those of other forms of hyperglycemia but can be subtle or easily attributed to normal pregnancy changes.

Typical Hyperglycemia-Related Symptoms: Some individuals report increased thirst, more frequent urination, fatigue, or blurred vision. These symptoms are not specific to gestational diabetes and can overlap with normal pregnancy, so their presence alone cannot confirm or exclude the diagnosis.
Pregnancy-Related Observations: Gestational diabetes is sometimes first suspected when an ultrasound shows a fetus that is large for gestational age, excess amniotic fluid (polyhydramnios), or accelerated fetal growth patterns, prompting further evaluation of maternal glucose levels.

Complications

What are the potential complications associated with this condition?

Untreated or inadequately controlled gestational diabetes increases the risk of multiple complications during pregnancy, delivery, and the postpartum period, as well as long-term cardiometabolic consequences for both the parent and child.

Maternal Complications In Pregnancy: Gestational diabetes raises the risk of gestational hypertension and preeclampsia, polyhydramnios, and the need for induction of labor. It can also unmask previously unrecognized type 2 diabetes or, in rare cases, lead to more severe hyperglycemic states.
Delivery-Related Complications: Individuals with gestational diabetes have higher rates of cesarean delivery and operative vaginal birth. Large fetal size and altered labor dynamics increase the risk of shoulder dystocia and birth trauma, particularly if glucose levels are not well controlled.
Neonatal Complications: Infants born to parents with gestational diabetes face increased risk of macrosomia, neonatal hypoglycemia, jaundice, respiratory distress, low Apgar scores, and admission to neonatal intensive care. In severe or poorly controlled cases, the risks of stillbirth and perinatal mortality also rise.
Long-Term Maternal Health Risks: After a pregnancy complicated by gestational diabetes, the parent has a markedly increased risk of type 2 diabetes, with meta-analyses estimating a several-fold elevation in risk and lifetime progression rates that can approach 40 to 70 percent in some cohorts. Gestational diabetes also signals a higher long-term risk of cardiovascular disease and metabolic syndrome.
Long-Term Child Health Risks: Children exposed to gestational diabetes in utero have higher rates of childhood obesity, glucose intolerance, and later type 2 diabetes and cardiovascular disease. Emerging evidence suggests an elevated risk of certain neurodevelopmental conditions, although the absolute risk for an individual child remains modest.

Diagnosis and Screening

How is gestational diabetes screened for and diagnosed?

Because gestational diabetes is often silent, structured screening between 24 and 28 weeks of gestation is standard in many health systems, with earlier testing for individuals at high risk. Multiple professional bodies provide guidance on one-step and two-step testing strategies.

Screening Strategies During Pregnancy: Two main approaches are used. In the one-step method, a fasting 75-gram oral glucose tolerance test is performed at 24 to 28 weeks, with blood glucose measured at fasting, 1 hour, and 2 hours; a diagnosis is made if any value meets or exceeds the defined thresholds. In the two-step method, a non-fasting 50-gram glucose challenge test is performed first, followed by a diagnostic 100-gram oral glucose tolerance test if the screening result exceeds a specified cutoff.
Gestational Age and Early Testing: Standard screening occurs in mid-pregnancy. However, individuals with significant risk factors, such as prior gestational diabetes, known pre-diabetes, or obesity, may be tested at the first prenatal visit to identify pre-existing diabetes or early hyperglycemia, and then retested later if initial results are normal.
Diagnostic Criteria and Interpretation: Diagnostic thresholds are based on glucose levels associated with increased risks of adverse pregnancy outcomes in large studies. Criteria endorsed by major organizations differ slightly in exact cutoffs and the number of elevated values required, but all aim to identify clinically meaningful hyperglycemia in which intervention improves outcomes.

Management and Treatment

How is gestational diabetes managed during pregnancy?

The goals of management are to maintain maternal blood glucose in target ranges, reduce the risks of obstetric and neonatal complications, and support long-term health for both parent and child. Treatment typically combines medical nutrition therapy, physical activity, glucose monitoring, and, when needed, pharmacologic therapy, along with careful obstetric surveillance.

Medical Nutrition Therapy: Dietary counseling emphasizes regular meals and snacks, controlled carbohydrate intake, a focus on high-fiber, nutrient-dense foods, and avoidance of concentrated sugars. Plans are individualized to cultural preferences, nutritional needs, and glycemic responses, and are ideally developed with a registered dietitian experienced in diabetes during pregnancy.
Physical Activity: Unless contraindicated, moderate physical activity, such as walking, prenatal exercise programs, or other low-impact activities, can improve insulin sensitivity and help maintain glycemic targets. Activity recommendations are tailored to the person’s baseline fitness, pregnancy status, and any obstetric complications.
Self-Monitoring of Blood Glucose: Individuals with gestational diabetes are typically advised to monitor blood glucose at home, often fasting and after meals, to identify patterns and adjust treatment. Glucose targets are slightly tighter than in many non-pregnant individuals because fetal outcomes are closely related to maternal glycemic control.
Pharmacologic Therapy: If lifestyle measures alone do not maintain glucose within target ranges, medication is added. Insulin is the standard first-line pharmacologic therapy in many guidelines because it does not cross the placenta and can be precisely titrated. Some protocols also use selected oral agents, such as metformin, after careful counseling regarding benefits and uncertainties.
Fetal Surveillance and Timing of Delivery: Depending on glycemic control, fetal size, and the presence of other complications, additional ultrasounds and antenatal testing may be recommended. Gestational diabetes that is well controlled with diet alone often allows expectant management to term, while more complex cases may involve planned delivery slightly earlier to balance maternal and fetal risks.

Postpartum Care and Long-Term Follow-Up

What follow-up is needed after delivery?

Glucose levels often improve rapidly after the placenta is delivered, but gestational diabetes reveals an underlying tendency toward future metabolic disease. Structured postpartum follow-up is essential for detecting persistent diabetes and supporting the prevention of type 2 diabetes.

Immediate Postpartum Period: In most cases, insulin and other glucose-lowering medications can be reduced or discontinued soon after birth, with blood glucose monitored in the first days to document resolution of pregnancy-related hyperglycemia. Breastfeeding is encouraged and may confer additional metabolic benefits for both parent and infant.
Postpartum Diabetes Screening: Professional guidelines recommend a 75-gram oral glucose tolerance test at approximately 4 to 12 weeks postpartum to assess for persistent diabetes or prediabetes, because fasting glucose and A1C alone may miss some cases. Individuals with normal results should still receive regular lifetime screening, often at intervals of one to three years, due to the ongoing elevated risk.
Long-Term Risk Reduction: Lifestyle measures such as balanced nutrition, regular physical activity, weight management, and smoking cessation can substantially reduce progression to type 2 diabetes in people with prior gestational diabetes. Coordination between obstetric, primary care, and endocrinology teams supports sustained prevention efforts.

Prevention

Can gestational diabetes be prevented?

Not every case of gestational diabetes can be prevented, but several strategies can reduce risk and improve outcomes. Interventions before conception and early in pregnancy are especially important for individuals with known risk factors.

Preconception Optimization: Achieving a healthy body weight, addressing pre-existing glucose abnormalities, and optimizing management of conditions such as polycystic ovary syndrome before pregnancy can lower risk. Preconception counseling offers an opportunity to review family history, medications, and metabolic health.
Early Pregnancy Assessment: For people at elevated risk, early glucose testing can identify undiagnosed type 2 diabetes or significant hyperglycemia before standard screening, allowing prompt treatment and counseling about pregnancy risks and management.
Lifestyle Measures During Pregnancy: Healthy eating patterns, appropriate gestational weight gain, and regular, safe physical activity throughout pregnancy can lower the likelihood of gestational diabetes and may reduce its severity if it develops.

Living With Gestational Diabetes

How can someone cope with gestational diabetes during and after pregnancy?

Gestational diabetes adds another layer of monitoring and decision-making to an already complex life stage. With coordinated care, most pregnancies affected by gestational diabetes result in healthy outcomes, and many people appreciate having a clear framework to protect their own health and that of their child.

Multidisciplinary Care and Education: Care often involves obstetric clinicians, diabetes specialists, nurses, and dietitians. Education on glucose monitoring, nutrition, physical activity, and signs of complications equips patients and families to participate actively in management and respond promptly if complications arise.
Emotional and Practical Support: Gestational diabetes can trigger worry, guilt, or frustration. Emotional support from partners, family, peer groups, mental health professionals, and community resources can help individuals manage stress, adhere to treatment plans, and maintain a sense of control during pregnancy and after delivery.
Planning Future Pregnancies: People with a history of gestational diabetes benefit from early consultation before subsequent pregnancies to reassess risk factors, update testing plans, and review strategies to reduce recurrence. This planning can improve outcomes in future pregnancies and support long-term cardiometabolic health.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.